News

This past year came with a multitude of new FDA approvals for antiretroviral therapies as well as research highlighting HIV and various comorbidities.

A new imaging technique may provide improvements to the diagnosis and treatment of diseases like age-related macular degeneration (AMD).

Children with asthma were less likely to have an ER visit if their families received greater SNAP benefits than if their family received a smaller benefit.

FeNO monitoring has been recommended as an assessment tool to determine whether patients who are on high-dose inhaled corticosteroids or low-dose oral corticosteroids have residual inflammation.

Living in rural areas and coal burning for heat were found to be risk factors for developing COPD.

Highly-purified cannabidiol (CBD) marketed as Epidiolex can lower the chances of seizures in adults and children with epilepsy.

What if insights from population data were able to help doctors predict a potential diagnosis months or even years earlier and be used to monitor these patients after a diagnosis is made?

Molecular testing for HCV and other infectious diseases can be done successfully in a point-of-care setting, but a new study says participation rates might be driven down in HIV is mentioned.

Tolsura was approved for patients with blastomycosis, histoplasmosis, and aspergillosis—infections most commonly associated with immunocompromising diseases such as HIV/AIDS or chronic rheumatic disorders.

Patients with epilepsy who live in high crime areas of Chicago had 3 times the rate of seizures as those in low crime neighborhoods.

New research finds posttraumatic growth is an important positive factor in life satisfaction for patients with HIV, even after controlling for the negative consequences of stigma and disclosure regret.

The ethically dubious physician says he has no regrets. Here’s why.

In 2018, investigators confirmed that one of the staple symptoms of multiple sclerosis—white matter demyelination—isn't always consistent.

The FDA has approved Atlantic Therapeutics’ INNOVO, the first non-invasive therapy device for stress urinary incontinence.

The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.

The study found that some C difficile spores can survive the commercial laundry process and may contribute to C difficile outbreaks.

Investigators examined the latest clinical guideline updates for C difficile testing.

In a clinical trial, the reSET-O app increased retention in an outpatient opioid use disorder treatment program.

The immunoassay uses automated clinical chemistry analyzers to provide a quantitative measure of plazomicin in human plasma.

African-American patients with moderate or severe sleep apnea have twice, or 3.5 times, the risk of resistant hypertension, respectively.

Pulmonary rehab is a program of exercise and education that is proven to increase exercise capacity, reduce symptoms, and elevate quality of life for patients, and is recommended in all major professional society guidelines in the US, Europe, and Canada.

Misleading information and unclear information can skew patients’ expectations of experimental treatments.

The decision to modify a disease-modifying multiple sclerosis therapy in the face of declining cognitive function could rest on whether the measure of decline marks worsening of disease.

Providers should be aware that periodontal disease may hinder the efficacy of blood pressure medication.

The seemingly complicated maneuvers of getting patient’s cholesterol better can be resolved with common sense. What’s best for the patient?

Children with autism spectrum disorder abnormal EEG results were more similar to children with epilepsy than to children with normal EEG results.

Since the PCSK9 inhibitors were approved for cholesterol management by the FDA in 2015, they have been frequently compared.

The Regeneron Pharmaceuticals and Sanofi-collaborated biologic became a tour de force in pulmonological care in 2019.

Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.

About half of all MS patients experience an episode of depression during their lifetimes, but most interventions are drug-related or psychiatric.